Molecular docking and dynamic simulation evaluation of Rohinitib — Cantharidin based novel HSF1 inhibitors for cancer therapy

Chidambaram, 2011, Nanotherapeutics to overcome conventional cancer chemotherapy limitations, J. Pharm. Pharm. Sci., 14, 67, 10.18433/J30C7D Akhtar, 2014, Targeted anticancer therapy: overexpressed receptors and nanotechnology, Clin. Chim. Acta, 436, 78, 10.1016/j.cca.2014.05.004 Au, 2009, Identification of inhibitors of HSF1 functional activity by high-content target-based screening, J. Biomol. Screen., 14, 1165, 10.1177/1087057109347472 Luo, 2009, Principles of cancer therapy: oncogene and non-oncogene addiction, Cell, 136, 823, 10.1016/j.cell.2009.02.024 Wang, 2006, Phosphorylation of HSF1 by MAPK-activated protein kinase 2 on serine 121, inhibits transcriptional activity and promotes HSP90 binding, J. Biol. Chem., 281, 782, 10.1074/jbc.M505822200 Mendillo, 2012, HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers, Cell, 150, 549, 10.1016/j.cell.2012.06.031 Shamovsky, 2008, New insights into the mechanism of heat shock response activation, Cell. Mol. Life Sci., 65, 855, 10.1007/s00018-008-7458-y Kim, 2013, The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters, J. Biol. Chem., 288, 28713, 10.1074/jbc.M113.488346 Meng, 2010, Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis, Oncogene, 29, 5204, 10.1038/onc.2010.277 Solimini, 2007, Non-oncogene addiction and the stress phenotype of cancer cells, Cell, 130, 986, 10.1016/j.cell.2007.09.007 Dai, 2007, Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis, Cell, 130, 1005, 10.1016/j.cell.2007.07.020 Whitesell, 2009, Inhibiting the transcription factor HSF1 as an anticancer strategy, Expert Opin. Ther. Targets, 13, 469, 10.1517/14728220902832697 Santagata, 2013, Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state, Science, 341, 1238303, 10.1126/science.1238303 Basmadjian, 2013, Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A, Future Med. Chem., 5, 2185, 10.4155/fmc.13.177 Laskowski, 1993, PROCHECK: a program to check the stereochemical quality of protein structures, J. Appl. Crystallogr., 26, 283, 10.1107/S0021889892009944 Bowie, 1991, A method to identify protein sequences that fold into a known three-dimensional structure, Science, 253, 164, 10.1126/science.1853201 Colovos, 1993, Verification of protein structures: patterns of nonbonded atomic interactions, Protein Sci., 2, 1511, 10.1002/pro.5560020916 Pronk, 2013, GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit, Bioinformatics, 29, 845, 10.1093/bioinformatics/btt055 Gallivan, 1999, Cation–π interactions in structural biology, Proc. Natl. Acad. Sci. U. S. A., 96, 9459, 10.1073/pnas.96.17.9459 Gromiha, 2004, Locating the stabilizing residues in (α/β) 8 barrel proteins based on hydrophobicity, long-range interactions, and sequence conservation, Proteins: Struct. Funct. Bioinf., 55, 316, 10.1002/prot.20052 Yang, 2013, Protein–ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment, Bioinformatics, 29, 2588, 10.1093/bioinformatics/btt447 De Castro, 2006, ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins, Nucleic Acids Res., 34, W362, 10.1093/nar/gkl124 SchuÈttelkopf, 2004, PRODRG: a tool for high-throughput crystallography of protein–ligand complexes, Acta Crystallogr. Sect. D: Biol. Crystallogr., 60, 1355, 10.1107/S0907444904011679 Wolber, 2006, Efficient overlay of small organic molecules using 3D pharmacophores, J. Comput. Aided Mol. Des., 20, 773, 10.1007/s10822-006-9078-7 Agarwal, 2014, In Silico Study to elucidate inhibitory effect of thiazides on plasmepsins: implications of new antimalarial drug design, Int. J. Pharm. Pharm. Sci., 6, 379 Macindoe, 2010, HexServer: an FFT-based protein docking server powered by graphics processors, Nucleic Acids Res., 38, 444, 10.1093/nar/gkq311 Van Dijk, 2009, 3D-DART: a DNA structure modelling server, Nucleic Acids Res., 37, W235, 10.1093/nar/gkp287 Wu, 1986, Human HSP70 promoter contains at least two distinct regulatory domains, Proc. Natl. Acad. Sci. U. S. A., 83, 629, 10.1073/pnas.83.3.629